Drug Discovery Solutions
-
Cell Line Development Solutions
5/15/2023
Discover technology that enables a cost-effective, easily implemented cell line development workflow while delivering high productivity pools and cell lines.
-
Discover Our iPSC Differentiated Cell Services
9/30/2025
iPSC-differentiated cell lines combine scalability and biorelevance, enabling precise disease modeling, drug screening, and regenerative research with customizable lineage-specific differentiation options.
-
Analytical Labs Particle Analysis
Particulate in a drug product represents a huge risk not only to patient safety – but also to a drug company’s reputation and bottom line. As concern about particulate rises, partnering with a particle analysis team enables customers to gain an intimate understanding of particle sources related to packaging and delivery systems.
-
TARGATT™ HEK293 Kits
9/30/2025
Accelerate cell line development for library creation and protein expression with efficient TARGATT™ large knock-in technology.
-
PUREplatform PUREcoli, A Pure Microbial Strain For Protein Production
3/17/2023
PUREplatform offers a platform, a premium strain, and cutting-edge screening, which together yield optimal protein expression that is uniquely tailored to each project.
-
Bioengineering Solutions Using A Fully Integrated Ecosystem
5/30/2023
Find solutions to meet your gene, protein, antibody, or cell line needs using two gene synthesis platforms that enable the design of constructs optimized for maximal expression/yield in your system.
-
TARGATT™ CHO Cells: Rapid, Stable CHO Cell Generation For Bioproduction
9/30/2025
With our proprietary TARGATT™ technology for site-specific integration of large DNA fragments, we’ve developed a series of TARGATT™ “master” cell lines, including engineered CHO.
-
NanoAssemblr® Spark™: Freedom To Discover
4/14/2022
The NanoAssemblr® Spark™ is ideal for nanomedicine formulation discovery and screening at microliter scales.
-
Drug Substance Synthesis And Manufacturing
3/3/2022
We take an agile and flexible approach with our customers programs, offering bespoke drug substance synthesis and manufacturing, helping to accelerate molecules from candidate selection to clinical proof-of-concept and onwards towards commercial scale.
-
Pharma Services Fill, Finish & Drug Delivery CDMO
11/7/2025
Sterile fill-finish and device assembly capabilities span global sites, offering scalable solutions, analytical testing, and regulatory compliance for combination products and small-batch technical programs.